ANTIVIRAL THERAPY FOR HEPATITIS IN DIALYSIS PATIENTS: ALMATY CASE SERIES
2 2025
Изменен: 30.04.2025Путь: Главная / Публикации
ANTIVIRAL THERAPY FOR HEPATITIS IN DIALYSIS PATIENTS: ALMATY CASE SERIES
11401 11402 11403 11404 11405 11406 9644 11291 11407 11408 7666 11409 11410 11411 11412 2 2025
Изменен: 30.04.2025Путь: Главная / Басты бет / Жарияланымдар
ANTIVIRAL THERAPY FOR HEPATITIS IN DIALYSIS PATIENTS: ALMATY CASE SERIES
... 2025 10.34689/SH.2024.27.2.027 Background: Patients with end-stage renal disease (ESRD) undergoing hemodialysis represent a high-risk group for chronic viral hepatitis... ... (HCV) infection in this population. However, local data from Central Asia, particularly Kazakhstan, remain limited. Aim: To evaluate the efficacy and safety of antiviral therapy... ... nucleos(t)ide analogs for HBV (entecavir or tenofovir). Sustained virological response (SVR12 and SVR24), liver function parameters, fibrosis regression (assessed via FibroScan)...
Изменен: 30.04.2025Путь: Главная / Home / Publications
Результаты поиска 1 - 3 из 3
Начало | Пред. | 1 | След. | Конец
Отсортировано по релевантности | Сортировать по дате